News by Davit Kirakosyan on Investing.com

Enphase Energy shares plunge 15% on guidance miss By Investing.com - Apr 25, 2023

Enphase Energy (NASDAQ:ENPH) shares dropped more than 15% after-hours following the company’s reported Q1 earnings results. While Q1 EPS of $1.37 and revenue of $726 million came...

Visa shares rise 2% on Q2 beat By Investing.com - Apr 25, 2023

Visa (NYSE:V) shares rose more than 2% after-hours following the company’s reported Q2 results, with EPS of $2.09 coming in better than the consensus estimate of $1.99. Revenue...

Apple to launch AI-Powered health coaching service & emotion tracker By Investing.com - Apr 25, 2023

Apple (NASDAQ:AAPL) is set to launch a new AI-powered health coaching service, codenamed Quartz, according to a Bloomberg report, which cited sources familiar with the matter. The...

6 big analyst cuts: Microsoft cut down ahead of earnings | Pro Recap By Investing.com - Apr 25, 2023

Investing.com -- Here is your daily Pro Recap of the biggest analyst cuts you may have missed since yesterday.As always, InvestingPro users got this news in real time.Microsoft...

5 big analyst picks: SAP snags 2 upgrades after Q1 miss | Pro Recap By Investing.com - Apr 25, 2023

Investing.com -- Here is your daily Pro Recap of the biggest analyst picks you may have missed since yesterday.SAP receives two upgrades following Q1 missCiti upgraded SAP...

Walt Disney price target raised at Wells Fargo, 'Best Opportunity in Media' By Investing.com - Apr 25, 2023

Wells Fargo raised the price target on Walt Disney (NYSE:DIS) to $147.00 from $141.00 while maintaining an Overweight rating, viewing it as the top idea in media. According to...

Ideaya Biosciences upgraded to Buy, shares jump on positive Interim Phase 2 data for Darovasertib and Crizotinib combination By Investing.com - Apr 24, 2023

Stifel upgraded Ideaya Biosciences (IDYA) to Buy from Hold and raised its price target to $24.00 from $18.00 on increased conviction in the Darovasertib 1L MUM opportunity. Shares...

Alphabet’s price target cut on more conservative long-term margin estimates By Investing.com - Apr 24, 2023

Oppenheimer lowered the price target on Alphabet (NASDAQ:GOOGL) to $135.00 from $155.00 while maintaining an Outperform rating after revisiting 2024/2025 margins and updating the...

5 big analyst cuts: First Solar slashed to Sell ahead of Q1 | Pro Recap By Investing.com - Apr 24, 2023

By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest analyst cuts you may have missed since Friday’s close.First Solar downgraded at Citi ahead of...

5 big analyst picks: Medtronic called a buy on FDA approval | Pro Recap By Investing.com - Apr 24, 2023

By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest analyst picks you may have missed since Friday’s close: fresh buy ratings at Medtronic, Live...